In 2025 12, Zhongguo Pharmaceutical Technology (Hebei) Co., Ltd. was officially selected as a member of the "Brand Powerhouse · Preferred Independent Brand Project" in the healthcare industry.
This initiative is a national platform launched by authoritative institutions to implement the country's strategy for building a brand powerhouse, dedicated to supporting high-quality development of independent brands and identifying industry-leading benchmarks. This recognition not only represents a nationally authoritative endorsement of Zhongguo Pharmaceutical's brand-building capabilities, research innovation strength, and market influence in the health sector, but also marks the company's formal entry as a key participant and practitioner in the national brand strategy.
Driven by the mission to tirelessly advance human health, Zhongguo Pharmaceutical places R&D at its core and extends value through professional health services. We continuously build a full-chain health ecosystem covering prevention, intervention, and management—delivering scientific, trustworthy health solutions to the public.
Looking ahead, Zhongguo Pharma will take this as a new starting point to proactively align with the "Healthy China 2030" national strategy. We will strengthen our own brand at a higher standard, accelerate technology transfer and commercialization at a deeper level, and continuously enhance our brand's core competitiveness. Through these efforts, we are committed to serving the nation's strategic goals and improving people's well-being, contributing to high-quality development in the broader health sector.